Clinical Trial Update: Effectiveness and Safety of Synvisc® Versus Usual Treatments in Patients With Knee Osteoarthritis [Phase 4]

View source ↗

Summary

A Phase 4 trial assessing the effectiveness and safety of Synvisc (hylan G-F 20) injections versus usual treatments in knee osteoarthritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Knee Osteoarthritis

Drugs mentioned

• Synvisc (Hylan G-F 20)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Osteoarthritis | Phase 4 | Status: COMPLETED